Gietema JA
Gietema JA
Professor of Medical Oncology, University Medical Center Groningen
Verified email at
Cited by
Cited by
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer
J. Clin. Oncol. 18, 1725-1732, 2000
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
F Bensch, EL van der Veen, MN Lub-de Hooge, A Jorritsma-Smit, ...
Nature medicine 24 (12), 1852-1858, 2018
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer
AW van den Belt-Dusebout, R de Wit, JA Gietema, S Horenblas, ...
Journal of Clinical Oncology 25 (28), 4370-4378, 2007
Metformin: taking away the candy for cancer?
M Jalving, JA Gietema, JD Lefrandt, S de Jong, AKL Reyners, ROB Gans, ...
European journal of cancer 46 (13), 2369-2380, 2010
Prognostic versus predictive value of biomarkers in oncology
C Oldenhuis, SF Oosting, JA Gietema, EGE De Vries
European journal of cancer 44 (7), 946-953, 2008
Indium-111–labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer
PJ Perik, MN Lub-De Hooge, JA Gietema, WTA van der Graaf, ...
Journal of clinical oncology 24 (15), 2276-2282, 2006
Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose …
VAB van den Bogaard, BDP Ta, A van der Schaaf, AB Bouma, ...
Journal of Clinical Oncology 35 (11), 1171, 2017
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer
AW van den Belt-Dusebout, J Nuver, R de Wit, JA Gietema, ...
Journal of clinical oncology 24 (3), 467-475, 2006
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label …
CN Sternberg, I Skoneczna, JM Kerst, P Albers, SD Fossa, M Agerbaek, ...
The lancet oncology 16 (1), 76-86, 2015
Cardiovascular toxicity caused by cancer treatment: strategies for early detection
R Altena, PJ Perik, DJ Van Veldhuisen, EGE De Vries, JA Gietema
The lancet oncology 10 (4), 391-399, 2009
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma …
T Powles, MS van der Heijden, D Castellano, MD Galsky, Y Loriot, ...
The Lancet Oncology 21 (12), 1574-1588, 2020
Testicular cancer survivorship: research strategies and recommendations
LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ...
Journal of the national cancer institute 102 (15), 1114-1130, 2010
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer, J Busch, ...
Annals of oncology 24 (4), 878-888, 2013
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
HS Haugnes, GJ Bosl, H Boer, JA Gietema, M Brydøy, J Oldenburg, ...
J Clin Oncol 30 (30), 3752-63, 2012
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week …
F Eskens, CH Mom, AST Planting, JA Gietema, A Amelsberg, H Huisman, ...
British journal of cancer 98 (1), 80-85, 2008
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas, ...
Annals of oncology 29 (8), 1658-1686, 2018
The clinical trail of TRAIL
EW Duiker, CH Mom, S De Jong, PHB Willemse, JA Gietema, ...
European journal of cancer 42 (14), 2233-2240, 2006
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients
M MT, DJ van Veldhuiserf, JA Cietema, WV Dolsma, F Boomsma, ...
Long-term chemotherapy-related cardiovascular morbidity, 93, 2001
The metabolic syndrome in cancer survivors
EC De Haas, SF Oosting, JD Lefrandt, BHR Wolffenbuttel, DT Sleijfer, ...
The lancet oncology 11 (2), 193-203, 2010
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer
J Nuver, AJ Smit, BHR Wolffenbuttel, WJ Sluiter, HJ Hoekstra, DT Sleijfer, ...
Journal of clinical oncology 23 (16), 3718-3725, 2005
The system can't perform the operation now. Try again later.
Articles 1–20